Javascript must be enabled to continue!
Protective Effect of Murraya koenigii Against D-Galactose-Induced Cognitive Dysfunction in Swiss Albino Mice
View through CrossRef
Alzheimer's disease (AD) and age-associated cognitive deficits are primary neurodegenerative diseases and are commonly related to progressive impairment in memory, oxidative stress, neuro inflammation, and neuronal loss. Chronic D galactose administration has been widely utilized in experimental animals to induce aging-associated deficits and cognitive decline; it has been known to induce oxidative damage and trigger inflammatory reactions in an aged brain. Natural products that are rich in antioxidant and anti-inflammatory properties are being explored extensively for the potential therapy of neurodegenerative diseases. The main goal of this investigation was to evaluate the neuroprotective efficacy of Murraya koenigii extract in the case of D-galactose-induced cognitive deficits in Swiss albino mice. The Swiss albino mice were separated into five groups, i.e., Group I- Normal Control, Group II- Murraya koenigii extract 500 mg/kg Per se, Group III- D-galactose (1000mg/kg, s.c.) + Group IV- Murraya koenigii extract 250mg/kg + D-galactose (1000mg/kg, s.c.), Group V- Murraya koenigii extract 500mg/kg + D-galactose (1000mg/kg, s.c.). The cognitive functions of Swiss albino mice were assessed by the use of the Morris Water Maze, Passive Avoidance Test, and Open Field Test. The levels of antioxidant and pro-oxidant parameters, namely the concentrations of MDA, SOD, reduced GSH, and CAT in the cerebral cortex of animals, were quantified. The levels of AChE activity and the cytokines that promote inflammation, namely TNF-α, IL-1α, and IL-10, were also quantified. Brain tissues were prepared and stained with H&E for histopathological studies. The outcome suggests that treatment with Murraya koenigii may lead to the recovery of cognitive impairment by enhancing antioxidant, anti-inflammatory, and cholinergic actions to provide neuroprotection against D-galactose mediated neurodegeneration. This study may demonstrate the plant's potential as a therapeutic remedy for age-associated cognitive disorders and Alzheimer's disease.
National Institute of STEM Research
Title: Protective Effect of Murraya koenigii Against D-Galactose-Induced Cognitive Dysfunction in Swiss Albino Mice
Description:
Alzheimer's disease (AD) and age-associated cognitive deficits are primary neurodegenerative diseases and are commonly related to progressive impairment in memory, oxidative stress, neuro inflammation, and neuronal loss.
Chronic D galactose administration has been widely utilized in experimental animals to induce aging-associated deficits and cognitive decline; it has been known to induce oxidative damage and trigger inflammatory reactions in an aged brain.
Natural products that are rich in antioxidant and anti-inflammatory properties are being explored extensively for the potential therapy of neurodegenerative diseases.
The main goal of this investigation was to evaluate the neuroprotective efficacy of Murraya koenigii extract in the case of D-galactose-induced cognitive deficits in Swiss albino mice.
The Swiss albino mice were separated into five groups, i.
e.
, Group I- Normal Control, Group II- Murraya koenigii extract 500 mg/kg Per se, Group III- D-galactose (1000mg/kg, s.
c.
) + Group IV- Murraya koenigii extract 250mg/kg + D-galactose (1000mg/kg, s.
c.
), Group V- Murraya koenigii extract 500mg/kg + D-galactose (1000mg/kg, s.
c.
).
The cognitive functions of Swiss albino mice were assessed by the use of the Morris Water Maze, Passive Avoidance Test, and Open Field Test.
The levels of antioxidant and pro-oxidant parameters, namely the concentrations of MDA, SOD, reduced GSH, and CAT in the cerebral cortex of animals, were quantified.
The levels of AChE activity and the cytokines that promote inflammation, namely TNF-α, IL-1α, and IL-10, were also quantified.
Brain tissues were prepared and stained with H&E for histopathological studies.
The outcome suggests that treatment with Murraya koenigii may lead to the recovery of cognitive impairment by enhancing antioxidant, anti-inflammatory, and cholinergic actions to provide neuroprotection against D-galactose mediated neurodegeneration.
This study may demonstrate the plant's potential as a therapeutic remedy for age-associated cognitive disorders and Alzheimer's disease.
Related Results
Multipurpose Plant - Murraya koenigii
Multipurpose Plant - Murraya koenigii
Murraya koenigii, an aromatic tropical and sub-tropical plant belonging to
the Rutaceae family, is valued for its culinary, medicinal, and industrial applications.
Its fresh leaves...
Evaluation of Synergistic Hypolipidemic Activity of Murraya koenigii and Atorvastatin suspension in Hyperlipidemic rats
Evaluation of Synergistic Hypolipidemic Activity of Murraya koenigii and Atorvastatin suspension in Hyperlipidemic rats
The purpose of this study is to assess the hypolipidemic potential of formulated suspensions of atorvastatin, alcoholic extract of Murraya koenigii and their combination on hyperli...
Murraya Koenigii: An Aromatic Herb Bridging Culinary And Medicinal Traditions.
Murraya Koenigii: An Aromatic Herb Bridging Culinary And Medicinal Traditions.
Meethi neem is the popular name for Murraya koenigii Linn. The curry tree is indigenous to India and is found nearly everywhere on the Indian subcontinent, with the exception of th...
A PERCEPTIVE STUDY ON ANTI-INFLAMMATORY, ANTI-MICROBIAL, AND ANTI-FUNGAL PROPERTIES OF Murraya koenigii LEAVES
A PERCEPTIVE STUDY ON ANTI-INFLAMMATORY, ANTI-MICROBIAL, AND ANTI-FUNGAL PROPERTIES OF Murraya koenigii LEAVES
The aim of the present study is to evaluate the anti-inflammatory, anti-microbial and anti-fungal activity of Murraya koenigii leaves. The male wistar rats having weight (150-200g)...
In vitro anti-Chikungunya efficacy, antioxidant and anti-inflammatory potential of Murraya koenigii ethanolic extract
In vitro anti-Chikungunya efficacy, antioxidant and anti-inflammatory potential of Murraya koenigii ethanolic extract
Chikungunya virus is an arthropod-transmitted Alphavirus that causes severe arthralgia which may persist for weeks or years. Currently no licensed antivirals or vaccines are access...
Bioactivities of Murraya koenigii (Linn.) and Adina cordifolia (Roxb.)
Bioactivities of Murraya koenigii (Linn.) and Adina cordifolia (Roxb.)
The present study was designed to evaluate the antioxidant, cytotoxic, thrombolytic, membrane stabilizing and antimicrobial activities of methanol extracts and different organic so...
Comparative clinical efficacy of Murraya koenigii gel and chlorhexidine gluconate gel for improvement of oral health
Comparative clinical efficacy of Murraya koenigii gel and chlorhexidine gluconate gel for improvement of oral health
Comparative clinical efficacy of Murraya koenigii gel and Chlorhexidine gluconate gel for improvement of oral health
Introduction: Gingivitis is a non-destructive, plaque induced ...
In-Vitro Analysis of Murraya Koenigii Root extract with Colistin Against MDR Pseudomonas Aeruginosa
In-Vitro Analysis of Murraya Koenigii Root extract with Colistin Against MDR Pseudomonas Aeruginosa
Objectives: To analyze susceptibility of MDR Pseudomonas aeruginosa to chloroform root extract ofMurraya koenigii.Methodology: For this research Murraya koenigii chloroform root ex...

